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Abstract 
Review on ECM1, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
HGNC (Hugo): ECM1 
Location: 1q21.3 
DNA/RNA 
Description 
The gene was initially described as having 10 
exons. Afterwards an alternative spliced exon 5a was 
detected (Johnson et al., 1997). 
Transcription 
Four transcripts are described of which three 
transcripts have been identified by Northern blot 
analysis and 1 by PCR (Smits et al., 2000). 
ECM1a (lacks exon 5a, 1.8 kb); ECM1b (exon 5a 
and exon 7 are missing, 1.4 kb); ECM1c (contains 
exon 5a, 1.85 kb); ECM1d (splice variant in which 
71 bp of the 3' end of intron 1 are transcribed, 
resulting in a truncated 57 aa protein, only detected 
by PCR, DQ010946). 
A. ECM1 DNA. B. ECM1 transcripts. 
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Schematic representation of ECM1 and its four splice variants. ECM1 protein is divided in a signal sequence (19 aa) (black 
box) and four different domains based on the presence or absence of cysteines: an N-terminal cysteine-free domain (white box), 
two tandem repeats (green and gray box), and a C-terminal region (blue box). ECM1c differs from ECM1a containing 19 aa 
encoded by exon 5a, ECM1b results from an alternative trancript caused by splicing out exon 7 (shaded black). ECM1d encodes 
a truncated protein composed of 57 aa containing exon 1, exon 2 and a part of exon 3. 
 
 
Protein 
Expression 
ECM1a is widely expressed in liver, small intestines, 
lung, ovary, prostate, testis, skeletal muscle, 
pancreas, kidney, placenta, heart, basal 
keratinocytes, dermal blood vessels, and adnexal 
epithelia including hair follicles and sweat glands 
(Smits et al., 1997). ECM1 overexpression has also 
been identified in corneal epithelium (Turner et al., 
2007) and epididymal tissue. In the latter, it has been 
proposed as a potential biomarker to distinguish 
obstructive from non-obstructive azoospermia based 
on the analysis of levels of the protein in seminal 
fluid (Drabovich et al., 2013). 
ECM1b is detectable in tonsils and the spinous and 
granular layers of the epidermis. 
ECM1c is expressed in the basal layer of the 
epidermis. ECM1 expression in human skin is 
regulated by age and ultraviolet light exposure and 
as such, may be a cutaneous stress response (Sander 
et al., 2006). 
Important remark: ECM1 antibodies available to 
detect ECM1 protein are not able to discriminate 
between ECM1a and ECM1c. 
ECM1d: expression pattern is not known yet. 
Localisation 
Ultrastructurally, ECM1a/c is a basement membrane 
protein in human skin and is part of network-like 
suprastructures containing perlecan (Mongiat et al., 
2003), collagen type IV and laminin 332 as 
constituents. 
Function 
The exact biological function of ECM1 is not 
elucidated yet, but evidence for its involvement in 
important biophysiological processes, like skin 
differentiation, endochondral bone formation and 
angiogenesis have now emerged. ECM1 inhibits the 
hypertrophy of chondrocytes as well as 
mineralization of the matrix and endochondral bone 
formation. In the broader context of skin biology, 
ECM1 appears to have many functions and 
particular a 'biological super-glue' action has been 
hypothesized. ECM1 also appears to have a role in 
regulating migration of type 2 helper T cells (Li et 
al., 2011). 
Homology 
Homology and protein-protein interactions: a 
computationally predicted three-dimensional 
structure of ECM1a is depicted below. 
Based on the third serum albumin domain ECM1a 
protein can be divided into four domains. The first 
domain containing alpha-helices (alphaD1) and 
three serum albumin subdomain-like domains 
(SASDL 2-4), each of three sequences comparable 
with a complete subdomain of the third serum 
albumin domain. AlphaD1 exits only of Alpha-
helices, whereas SASDL2 and -3 are capable of 
binding most of the extracellular matrix proteins 
identified so far (collagen type IV, laminin 332, 
fibronectin, perlecan, fibulin 1C/D, fibulin-3 and 
MMP-9) (Sercu et al., 2009; Sercu et al., 2008; 
Fujimoto et al., 2005). Other cDNA clones known to 
react with ECM1 fragments in (yeast two-hybrid 
asays) include legumain, human insulin-like growth 
factor, epidermal growth factor, human chorionic 
somatomammotropin, human alpha 2 hemoglobin, 
NADH dehydrogenase and ubiquinone (Fujimoto et 
al., 2006). 
ECM1 also binds COMP (cartilage oligometric 
matrix protein) both in vitro and in vivo via the 
COMP EGF domain (Kong et al., 2010). In addition, 
ECM1 also binds the type II transmembrane protein 
PLSCR1 (phospholipid scramblase 1) via its tandem 
repeat region (Merregaert et al., 2010). 
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Computationally predicted three-dimensional structure of ECM1a. 
 
 
Mutations 
Mutations were described in lipoid proteinosis (LiP; 
OMIN#247100), also known as hyalinosis cutis et 
mucosae or Urbach-Wiethe disease. This is a rare, 
autosomal recessive disorder characterized by 
generalized thickening of skin, mucosae, and certain 
viscera. Histologically, there is widespread 
deposition of hyaline (glycoprotein) material and 
disruption/reduplication of basement membrane. 
Classic features include beaded eyelid papules and 
laryngeal infiltration leading to hoarseness. More 
than 40 distinct missense, nonsense, splice site, small 
and large deletions and insertions have been 
reported, as summarized in Table 1. Approximately 
50% of the mutations cluster to exon 6 and 7 of the 
gene. Examining the immunostaining pattern of skin 
biopsies using anti-ECM1 antibody can be used for 
the rapid diagnosis of LiP (Chan et al., 2004c). 
Implicated in 
Various cancers 
A survey of ECM1 expression in different tumors 
indicated that ECM1, although not tumor specific, is 
significantly elevated in many malignant epithelial 
tumors that gave rise to metastases (Wang et al., 
2003). ECM1 overexpression has been described in 
cancers of the breast, thyroid (Lal et al., 2008; 
Kebebew et al., 2005; Pauws et al., 2004) and head 
and neck squamous cell carcinomas (HNSCC), 
specifically, laryngeal carcinomas. Other 
carcinomas with increased ECM1 expression 
include hepatocellular carcinoma, 
cholangiocarcinomas, cutaneous melanoma cell 
lines (Lal et al., 2013) and gastric carcinomas (Wu et 
al., 2014).  
In addition, ECM1 upregulation has been  
associated with poor prognosis and metastases in 
breast (Lal et al., 2009), laryngeal (Gu et al., 2013; 
Han et al., 2006), hepatocellular (Chen et al., 2011), 
gastric and cholangiocarcinomas (Xiong et al., 
2012). ECM1 expression also appears to be a 
predictor of primary uveal melanoma metastasis in a 
study using microarray expression (Onken et al., 
2010). 
Together with the observation that human 
recombinant ECM1 stimulates proliferation of 
cultured endothelial cells and promotes blood vessel 
formation in the chorioallantoic membrane of 
chicken embryos suggest that ECM1 is a possible 
trigger for angiogenesis, tumor progression and 
malignancies (Han et al., 2001). ECM1 has been 
correlated with elevated lymphatic and microvessel 
density in laryngeal (Han et al., 2006) and gastric 
tumors (Wu et al., 2014) and also correlated with 
estrogen responsiveness in breast cancer. In the latter 
ECM1 expression also correlates with VEGF-C 
suggesting that they may have a synergistic effect on 
lymphangiogenesis and facilitation of lymphatic 
metastases (Wu et al., 2012). In 
cholangiocarcinomas, ECM1 expression is also 
correlated with expression the tumor marker CA19-
9, MMP-9 and the estrogen receptor (Xiong et al., 
2012). 
ECM1 also appears to play a role in the migration, 
invasion and attachment properties of cancer cells, 
as seen in studies of cholangiocarcinoma and 
melanoma cell lines (Xiong et al., 2012; Lal et al., 
2013). 
Overexpression of ECM1 in cancer cells appears to 
be mediated by the Akt/NF-κB signaling axis (Xiong 
et al., 2012). ECM1 expression is also partly 
regulated by transcription factor AP2C (TFAP2C) in 
melanoma cells, and its effect is mediated by direct 
interaction with the ECM1 promoter (Lal et al., 
2013). 
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Table 1. Summary of ECM1 mutations in lipoid proteinosis. 
 
 
Lipoid proteinosis 
Disease 
Lipoid proteinosis, also known as hyalinosis cutis et 
mucosae or Urbach-Wiethe disease.  
Lipoid proteinosis is a rare autosomal recessive 
genodermatosis characterized by the deposition of an 
amorphous hyaline material in the skin, mucosa, and 
viscera. Papular infiltration of the margin of the lids 
producing 'itchy eyes', and infiltration in the tongue 
and its frenulum, in the larynx leading to hoarseness, 
and in the skin (e.g., elbows and axilla) are 
characteristic (Hamada et al., 2003; Hamada et al., 
2002). 
Lichen sclerosus et atrophicus 
Disease 
Lichen sclerosus (LS) is a chronic inflammatory skin 
disorder of unknown etiology that results in white 
plaques with epidermal atrophy. It has both genital 
and extragenital presentations. HLA-subtype 
susceptibility and high rates of other autoimmune 
disorders suggest that autoantibodies to specific 
mucocutaneous antigens may be involved in the 
etiology of lichen sclerosus. The similarities with 
lipoid proteinosis, which results from mutations in 
the ECM1 gene, suggested that this protein may be 
an autoantigen in lichen sclerosus. Indeed, 
circulating auto-antibodies to ECM1 were found in 
the sera of 67% of lichen sclerosus patients (Oyama 
et al., 2003; Oyama et al., 2004).  
In conclusion lipoid proteinosis and lichen sclerosus 
are immunogenetic counterparts targeting ECM1. 
Ulcerative colitis 
Note 
A nonsynonymous SNP (rs11205387) has been 
associated with ulcerative colitis (Fisher et al., 
2008). ECM1 variation was not associated with 
Crohn's disease (Anderson et al., 2009). 
Incorporation of the analysis of ECM1 genetic 
variants into a diagnostic algorithm including 
serological and inflammatory markers resulted in 
improved accuracy in identifying inflammatory 
bowel disease and in particular, differentiating 
between ulcerative colitis and Crohn's disease (Plevy 
et al., 2013). 
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